Modernizing Diagnosis | Sept. 18-19, 2024 | Tokyo, Japan, and Online
AAIC® Advancements: Modernizing Diagnosis will feature global perspectives on the science of Alzheimer’s diagnosis, detection and monitoring. Areas of focus include the Revised Criteria for Diagnosis and Staging of Alzheimer’s Disease, Treatment-Related Amyloid Clearance (TRAC), biomarker advancements, clinical case studies and more.
As science advances and evolves, so do approaches to describing and diagnosing Alzheimer's disease. In particular, we now have a better understanding of the changes in Alzheimer's biomarkers throughout the course of the disease. Join the global research community to discuss geographic-specific implications and considerations.
All were invited to submit abstracts on the latest research in Alzheimer's diagnosis, detection and monitoring. Abstract themes aligned with Scientific Sessions, including:
Companies interested in sponsoring AAIC Advancements: Modernizing Diagnosis can contact Tommy Morris, senior director of Corporate Initiatives, at tomorris@alz.org.
AAIC Advancements: Modernizing Diagnosis aims to provide a safe, equitable, and accessible experience for all conference participants.
Read the full Statement of Appropriate Conduct (PDF).
General questions: aaicadvancements@alz.org
Media questions: media@alz.org
Dates: Sept. 18-19, 2024
Location:
The Westin Tokyo, Japan, and online
Cost:
Abstract submission is now closed.
Network and collaborate year-round with ISTAART, a global community of scientists, clinicians and dementia professionals who are working to advance Alzheimer’s and dementia research and treatment.
We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.